ワシントンにおける血液がんの臨床試験
ワシントン内の拠点で、血液がんに関する20件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト（英語）
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Fred Hutchinson Cancer Center ( Site 0024), Bellevue
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- 他19件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
- Fred Hutchinson Cancer Research Center, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06697184Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Medical Oncology Associates (Summit Cancer Centers) ( Site 2710), Spokane
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT04728893Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Fred Hutchinson Cancer Research Center, Seattle
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07648264Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- 他18件
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/17更新 · NCT04242095Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- University of Washington, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT06001788Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
- Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/08/17更新 · NCT04515810PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- Fred Hutchinson Cancer Center, Seattle
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT06665100A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Fred Hutchinson Cancer Research Center, Seattle
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545IVIG for Infection Prevention After CAR-T-Cell Therapy
- Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT05952804211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Fred Hutch/University of Washington Cancer Consortium, Seattle
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/06/22更新 · NCT03670966Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
- Seattle Childrens Hospital, Seattle
被験者募集中観察研究
30歳以下 · 全性別 · 2026/06/18更新 · NCT06579469CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- University of Washington Medical Center, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT03328078Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
- Fred Hutchinson Cancer Centre, Seattle
被験者募集中第2相健康なボランティア歓迎
2歳以上 · 全性別 · 2026/04/16更新 · NCT06510699A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- Swedish Cancer Institute, Seattle
被験者募集中観察研究
18歳以上 · 全性別 · 2025/06/25更新 · NCT05768269PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
- University of Washington, Seattle
被験者募集中
18歳以上 · 全性別 · 2025/04/20更新 · NCT05956457Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Fred Hutchinson Cancer Center, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2025/04/15更新 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Seattle Children's Hospital, Seattle
被験者募集中第1相
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- Fred Hutchinson Cancer Center, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2024/11/15更新 · NCT06034275ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。